Associate Professor of Internal Medicine, Faculty of Medicine, Lund University
Associate Professor of Clinical Biochemistry, Faculty of Medicine, Lund University
General Practitioner, Center for Primary Health Care Research
Email: firstname.lastname@example.org Address:
Center for Primary Health Care Research
CRC, Building 28, Floor 11
Jan Waldenströms gata 35
Skåne University Hospital
205 02 Malmö
Swedish Heart-Lung Foundation-funded Researcher (2012-2014)
General Practitioner, Center for Primary Health Care Research (2011-)
Associate Professor of Internal Medicine, Faculty of Medicine, Lund University (2001-)
Associate Professor of Clinical Biochemistry, Faculty of Medicine, Lund University (1997-)
Honors and Awards
- International Prize for Congenital Coagulation Disorders from Fondazione Angelo Bianchi Bonomi, Milan (1995)
- Carl-Bertil Laurell’s Nordic Fund for Clinical Chemistry (1996)
- Astrup prize 1996 (3rd-5th place) (1996)
- TRIOLABS research scholarship for thrombosis and bleeding disorders (1997)
- Pfizer Fellowship (1998)
- Förderpreis für Nachwuchwissenschaftler 1998 der Gesellschaft für Thrombose und Hämostaseforschung (1998)
- Specialist in Family Medicine, The National Board of Health and Welfare (2009)
- Specialist in Internal Medicine, The National Board of Health and Welfare (2001)
- Specialist in Clinical Chemistry, The National Board of Health and Welfare (1996)
- PhD in Clinical Chemistry, Lund University (1996). Dissertation title: Familial thrombophilia: resistance to activated protein C and protein S deficiency
- MD, Lund University (1989)
Advisory Board member, Thrombosis and Haemostasis (1999)
Current Research Interests
My work focuses on epidemiology, including the genetic epidemiology of cardiovascular diseases. Special areas of interest include venous thromboembolism (VTE), atherosclerotic disorders, cancer, and atrial flutter, as well as the effects of family history. My colleagues and I are currently attempting to dissect the individual and combined contributions of familial and non-familial risk factors to VTE. We are also examining the relationships between VTE and other disorders such as atherosclerotic disorders and cancer. For instance, we have shown that VTE and CHD/stroke/cancer do not share strong inherited risk factors. Moreover, we have also shown that the different manifestations of VTE (including rare manifestations) all have a familial background.
Zöller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet. 2012;379:244-9.
Zöller B, Li X, Ohlsson H, Sundquist J, Sundquist K. Venous thromboembolism does not share strong familial susceptibility with ischemic stroke: a nationwide family study in Sweden. Circ Cardiovasc Genet. 2011;4:484-90.
Zöller B, Li X, Sundquist J, Sundquist K. Age- and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden. Circulation. 2011;124:1012-20.
Zöller B, Li X, Sundquist J, Sundquist K. Venous thromboembolism does not share strong familial susceptibility with coronary heart disease: a nationwide family study in Sweden. Eur Heart J. 2011; 32:2800-5.
Zöller B, Li X, Sundquist J, Sundquist K. Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden. J Thromb Haemost. 2011;9:64-70.